Health Disparities in the Treatment of Supraventricular Tachycardia in Pediatric Patients

Pediatr Cardiol. 2022 Dec;43(8):1857-1863. doi: 10.1007/s00246-022-02924-x. Epub 2022 May 10.

Abstract

Supraventricular tachycardia (SVT) is a common pediatric arrhythmia. The objective of this investigation was to investigate the existence and degree of the health disparities in the treatment of pediatric patients with supraventricular tachycardia based on sociodemographic factors. This was retrospective cohort study at a large academic medical center including children ages 5-18 years old diagnosed with SVT. Patients with congenital heart disease and myocarditis were excluded. Initial treatment and ultimate treatment with either medical management or ablation were determined. The odds of having an ablation procedure were determined based on patient age, sex, race, ethnicity, and insurance status. There was a larger portion of non-White patients (p = 0.033) within the cohort that did not receive an ablation during the study period. Patients that were younger, female, American Indian/Alaskan Native, unknown race, and had missing insurance information were less likely to receive ablation therapy during the study period. In this single center, regional evaluation, we demonstrated that disparities in the treatment of pediatric SVT are present based on multiple patient sociodemographic factors. This study adds evidence to the presence of inequities in health care delivery across pediatric populations.

Keywords: Health equity; Pediatric cardiology; Race and ethnicity; Socioeconomic status; Supraventricular tachycardia.

MeSH terms

  • Adolescent
  • Catheter Ablation* / methods
  • Child
  • Child, Preschool
  • Female
  • Heart Defects, Congenital* / surgery
  • Humans
  • Retrospective Studies
  • Tachycardia, Supraventricular* / diagnosis
  • Tachycardia, Supraventricular* / surgery
  • Treatment Outcome